Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.5 EUR | -1.66% |
|
-4.05% | +8.51% |
18/06 | T. Rowe Price Unveils New, Patent-Pending Framework | CI |
12/06 | Goldman Sachs Raises T. Rowe Price's PT to $113 From $110 | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company has a low valuation given the cash flows generated by its activity.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's enterprise value to sales, at 3.2 times its current sales, is high.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.51% | 25.75B | - | ||
-3.64% | 117B | A- | ||
+3.37% | 94.38B | C+ | ||
+26.70% | 67.18B | C | ||
+7.06% | 64.45B | - | B+ | |
+15.49% | 44.79B | C+ | ||
+12.18% | 42.43B | A- | ||
+23.34% | 37.37B | A- | ||
-5.03% | 22.29B | A- | ||
-0.84% | 18.39B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TROW Stock
- TR1 Stock
- Ratings T. Rowe Price Group Inc.